BRCA1 and neoplasm: The specificity, sensitivity, and consistency of TP53 and BRCA1 in circulating tumor‐free DNA and tumor tissue DNA were 100%, 73.7%, 76.2% and 100%, 75%, 95.24%, respectively (Table 4).